A smooth muscle cell lncRNA controls angiogenesis in chronic limb-threatening ischemia through miR-143-3p/HHIP signaling
Journal of Clinical Investigation · 15.10.2025 · 135 (20)
DOI: 10.1172/jci188559 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 28.08.2025. Verfasst von Ming Zhai und 15 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: MicroRNAs, RNA, Long Noncoding, Signal Transduction, Neovascularization, Physiologic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Peripheral artery disease (PAD) often advances to chronic limb-threatening ischemia (CLTI), resulting in severe complications such as limb amputation. Despite the potential of therapeutic angiogenesis, the mechanisms of cell-cell communication and transcriptional changes driving PAD are not fully understood. Profiling long noncoding RNAs (lncRNAs) from gastrocnemius muscles of participants with or without CLTI revealed that a vascular smooth muscle cell–enriched (SMC-enriched) lncRNA, CARMN, was reduced with CLTI. This study explored how a SMC lncRNA-miRNA signaling axis regulates angiogenesis in limb ischemia. CARMN-KO mice exhibited reduced capillary density and impaired blood flow recovery and tissue necrosis following limb ischemia. We found that CARMN-KO SMC supernatants inhibited endothelial cell (EC) proliferation, spheroid sprouting, and network formation. RNA-seq identified downregulation of the Hedgehog signaling pathway in CARMN-KO models and revealed that CARMN regulates this pathway through its downstream miRNA, miR-143-3p, which targets Hedgehog-interacting protein (HHIP), an antagonist of Hedgehog signaling. Delivery of HHIP-specific siRNA or miR-143-3p mimics rescued EC angiogenic defects and improved blood flow recovery in both CARMN-KO and WT mice. These findings underscore the critical role of CARMN in modulating angiogenesis through the miR-143-3p-HHIP-Hedgehog signaling axis, providing insights into SMC-EC interactions and potential therapeutic strategies for CLTI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
- Department of Cardiology, Tongji Hospital, Tongji University School of Medicine, Shanghai, China.
- Department of Applied Physiology and Kinesiology, University of Florida, Gainesville, Florida, USA.
Förderung
- NHLBI NIH HHS
- NIDDK NIH HHS
- National Institutes of Health
- American Heart Association
Zitieren
APA
Zhai, M., Jamaiyar, A., Qian, J., Wu, W. W., Bektik, E., Randhawa, V., Vaz, C., Pandey, A. K., Wara, A. K., Sachan, M., Hu, Y., Garcia, J. L., Alford, C. E., Ryan, T. E., Peng, W., & Feinberg, M. W. (2025). A smooth muscle cell lncRNA controls angiogenesis in chronic limb-threatening ischemia through miR-143-3p/HHIP signaling. Journal of Clinical Investigation, 135(20). https://doi.org/10.1172/jci188559
Vancouver
Zhai M, Jamaiyar A, Qian J, Wu WW, Bektik E, Randhawa V, et al. A smooth muscle cell lncRNA controls angiogenesis in chronic limb-threatening ischemia through miR-143-3p/HHIP signaling. Journal of Clinical Investigation. 2025;135(20). doi:10.1172/jci188559
BibTeX
@article{Zhai2025,
author = {Zhai, Ming and Jamaiyar, Anurag and Qian, Jun and Wu, Winona W and Bektik, Emre and Randhawa, Vinay and Vaz, Camila and Pandey, Arvind K and Wara, Akm Khyrul and Sachan, Madhur and Hu, Yi and Garcia, Jéssica L and Alford, Claire E and Ryan, Terence E and Peng, Wenhui and Feinberg, Mark W},
title = {A smooth muscle cell lncRNA controls angiogenesis in chronic limb-threatening ischemia through miR-143-3p/HHIP signaling},
journal = {Journal of Clinical Investigation},
year = {2025},
volume = {135},
number = {20},
doi = {10.1172/jci188559}
}
EUVIMED